Conventional fractionation should not be the standard of care for T2 glottic cancer

BACKGROUND: The aim of this study was to report outcomes and late toxicity following hypofractionated accelerated radiotherapy for T2 glottic cancers. We highlight the importance of hypofractionated treatments with shorter overall treatment times, in improving outcomes for T2 glottic cancers. We als...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Radiat Oncol
Egile Nagusiak: Dixon, Lynne M., Douglas, Catriona M., Shaukat, Shazril Imran, Garcez, Kate, Lee, Lip Wai, Sykes, Andrew J., Thomson, David, Slevin, Nicholas J.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2017
Gaiak:
Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5686811/
https://ncbi.nlm.nih.gov/pubmed/29137654
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13014-017-0915-8
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak